Both in Biotechnology
Acumen Pharmaceuticals vs TScan Therapeutics
Over the past year ABOS returned −88.9% and TCRX returned −81.3%; their daily moves had a correlation of 0.13.
ABOS −88.9% TCRX −81.3%Growth of $1, one year, split-adjusted
| Metric | ABOS | TCRX |
|---|---|---|
| Price | $0.2163 | $0.2100 |
| Market cap | $15.6M | $14.2M |
| Today | −7.72% | +11.11% |
| 1 month | −89.3% | −23.7% |
| 6 months | −91.6% | −83.2% |
| Year to date | −89.7% | −79.0% |
| 1 year | −90.1% | −83.1% |
| Revenue growth (YoY) | — | −65.8% |
| Gross margin | — | 100.0% |
| Net margin | — | −2888.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.0× |
| Net cash | $52.3M | $67.4M |
| Dividend yield | — | — |
| Volatility (60d) | 492.9% | 143.0% |
| Short % of float | 7.6% | 4.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).